Quick Facts
- Type
- Single
- Category
- Metabolic / Weight Loss
- Vial Strength
- 250 mg × 60 capsules
- Status
- Research
Research Purposes Only
This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.
Download Guide
Save the complete SLU-PP-332 250mg Capsules research guide as a PDF.
Educational and research use only. Not medical advice.
Reference
Sources used for this guide are listed in our research database .
What Is SLU-PP-332 250mg Capsules?
SLU-PP-332 250mg Capsules Capsules Overview
SLU-PP-332 Capsules provide this exercise mimetic ERRα/γ agonist at 250 mg per capsule (60 count). As an orally bioavailable small molecule, the capsule format is ideal for metabolic and endurance research without injection.
SLU-PP-332 250mg Capsules Quick Reference
SLU-PP-332 250mg Capsules Capsules Specifications
- Peptide
- SLU-PP-332 (Capsules) 250 mg / 60 ct (NNMT inhibitor)
- Vial Content
- 250 mg SLU-PP-332 per capsule, 60 capsules per bottle (15,000 mg total)
- Category
- Metabolic / Weight Loss
- Administration Method
- Oral capsule
- Common Use Case
- Exercise mimetic for endurance enhancement and metabolic rate elevation
SLU-PP-332 250mg Capsules Compared With Other Formats
Details that distinguish this 250 mg × 60 capsules format include:
- ERRα/γ dual agonist — activates mitochondrial biogenesis and oxidative metabolism
- Designated 'exercise mimetic' — shifts muscle fibers toward oxidative phenotype
- Improves endurance and fatigue resistance in preclinical models
- Oral capsule — no injection required
How Does SLU-PP-332 Work?
SLU-PP-332 Mechanism of Action
SLU-PP-332 is a potent agonist of estrogen-related receptors alpha and gamma (ERRα/γ), nuclear receptors that act as master regulators of mitochondrial biogenesis and oxidative metabolism. By activating ERRα/γ, SLU-PP-332 upregulates genes involved in fatty acid oxidation, mitochondrial electron transport, and oxidative fiber type switching. In preclinical models, treatment improved running endurance by ~70% and increased oxygen consumption.
What Are the Potential Benefits of SLU-PP-332?
SLU-PP-332 Research Findings and Observed Outcomes
Findings and reported areas of study for SLU-PP-332 (Capsules) 250 mg / 60 ct include:
- Improved endurance capacity (~70% in preclinical models)
- Increased mitochondrial biogenesis and oxidative metabolism
- Type I (oxidative) muscle fiber upregulation
- Enhanced fatty acid oxidation and energy expenditure
- Fatigue resistance improvements
These observations are discussed for research and educational reference only and are not medical claims.
What Do You Need to Use SLU-PP-332 250mg Capsules?
SLU-PP-332 250mg Capsules Supplies for Use and Handling
- •SLU-PP-332 capsule bottle
Supplies listed are for laboratory handling and research preparation purposes only.
SLU-PP-332 250mg Capsules Administration and Research Protocol
SLU-PP-332 Oral Route, Frequency and Timing
SLU-PP-332 250mg Capsules Dosage Guide
SLU-PP-332 Dosage Ranges
The ranges below pair the listed dose with the draw volume for this product strength.
SLU-PP-332 250mg Capsules Dosage Examples
Based on reconstitution below
| Target Daily Dose | Draw Volume | Units |
|---|---|---|
| 250 mg | 1 capsule | Once daily |
| 500 mg | 2 capsules | Once daily |
This dosing table is unique to the 250 mg × 60 capsules vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).
How Long Does SLU-PP-332 250mg Capsules Last?
SLU-PP-332 250mg Capsules Duration by Research Dose
At common research doses, one 250 mg × 60 capsules vial of SLU-PP-332 typically supports:
Continuous daily use. Preclinical protocols used chronic administration (4–8 weeks).
SLU-PP-332 250mg Capsules Preparation and Handling
SLU-PP-332 250mg Capsules Use and Handling Instructions
This section applies specifically to the SLU-PP-332 (Capsules) 250 mg / 60 ct.
- Recommended Diluent
- N/A — oral capsule
- Diluent Volume
- N/A
- Final Concentration
- 250 mg per capsule
SLU-PP-332 250mg Capsules Preparation Steps
- 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
- 2Wash hands thoroughly and prepare a clean workspace with all supplies.
- 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
- 4Clean the rubber stopper of the vial with an alcohol prep pad.
- 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
- 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
- 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.
SLU-PP-332 Stacks and Research Combinations
SLU-PP-332 and Compatible Research Pairings
In research settings, SLU-PP-332 (Capsules) 250 mg / 60 ct is sometimes paired with peptides such as:
Factors That May Affect SLU-PP-332 Research Outcomes
Supporting Factors for SLU-PP-332 Research
Factors recorded alongside this protocol include:
- Regular aerobic exercise amplifies ERRα/γ activation effects
- High-protein diet supports muscle fiber remodeling
- Adequate sleep for mitochondrial recovery and biogenesis
- Consistent daily dosing — cumulative effects build over weeks
These factors can affect how research observations are interpreted.
SLU-PP-332 Side Effects and Safety Considerations
SLU-PP-332 250mg Capsules Tolerability Notes
SLU-PP-332 is well tolerated in preclinical models. Human safety data is limited.
Some individuals report:
- Mild GI discomfort if taken on an empty stomach
- Increased energy expenditure may present as mild warmth
- Potential fatigue adjustment during the first 1–2 weeks
How to Store SLU-PP-332 Before and After Opening
SLU-PP-332 250mg Capsules Storage Requirements
- Unreconstituted
- Store at room temperature away from moisture and light
- Reconstituted
- N/A
- Post-Mix Stability
- Stable as packaged; follow expiration date
Who Should Avoid SLU-PP-332?
This peptide is generally not recommended for:
- Pregnant or breastfeeding individuals
- Anyone with hormone receptor-sensitive conditions
- Anyone advised otherwise by a qualified healthcare professional
SLU-PP-332 250mg Capsules FAQs
Does SLU-PP-332 replace exercise?
SLU-PP-332 activates many of the same molecular pathways as aerobic exercise but does not replicate all physiological effects of training. It is described as an 'exercise mimetic' that augments rather than fully replaces training.
How quickly do effects appear?
Preclinical models show measurable endurance and metabolic improvements within 4–8 weeks of consistent daily use.
Where to Buy SLU-PP-332 250mg Capsules for Research
SLU-PP-332 250mg Capsules Purchasing and Research Supply Notes
Before ordering SLU-PP-332 (Capsules) 250 mg / 60 ct, review the product label, available testing documents, and storage instructions.
Check the ResearchLabs listing for:
- Available testing documents
- Product strength and concentration
- Storage and handling instructions
- Current product availability
View the current listing for SLU-PP-332 (Capsules) 250 mg / 60 ct:
→ View on ResearchLabsConfirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.
Quick Facts
- Type
- Single
- Category
- Metabolic / Weight Loss
- Vial Strength
- 250 mg × 60 capsules
- Status
- Research
Research Purposes Only
This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.
Download Guide
Save the complete SLU-PP-332 250mg Capsules research guide as a PDF.
Educational and research use only. Not medical advice.
Reference
Sources used for this guide are listed in our research database .
